Health ❯Diabetes ❯Type 2 Diabetes

Treatment Options

Clinical Trials GLP-1 Agonists Injectable Medications GLP-1 Drugs Mounjaro vs Ozempic Ozempic Elenolic Acid Semaglutide Medications

5 ARTICLES

last mo.

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

The Danish pharmaceutical giant pivots strategically, securing global rights to UBT251 to compete with Eli Lilly's advanced treatments in the expanding weight-loss drug market.

6 ARTICLES

last mo.

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

3 ARTICLES

3mo ago

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients

13 ARTICLES

6mo ago

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy